ATRIAL FIBRILLATION AFTER CARDIAC SURGERY: PATHOPHYSIOLOGY AND PREVENTION TECHNIQUES
https://doi.org/10.21292/2078-5658-2017-14-1-58-66
Abstract
Atrial fibrillation is one of the most frequent complications occurring after cardiac surgery. Post-operative atrial fibrillation confidently increases the risk of mortality and associated complications. Pathogenesis of this disorder is frequently based on combination of several promoting factors. A major number of studies has been performed among cardiac surgery patients in order to search for effective drug therapy or other surgical techniques aimed at post-operative atrial fibrillation prevention. At present none of the suggested prevention treatment can assure secure protection from post-operative atrial fibrillations and associated complications. Therefore new studies are needed aimed at the detail investigation of pathophysiology of this disorder and development of effective prevention and treatment methods.
About the Authors
V. V. Lomivorotov
E. N. Meshalkin Research Institute of Blood Circulation Pathology, Novosibirsk
Russian Federation
Doctor of Medical Sciences, Professor, Deputy Director for Research, Head of Anesthesiology and Intensive Care Center
Russian Federation
Doctor of Medical Sciences, Professor, Deputy Director for Research, Head of Anesthesiology and Intensive Care Center
S. M. Efremov
E. N. Meshalkin Research Institute of Blood Circulation Pathology, Novosibirsk
Russian Federation
Doctor of Medical Sciences, Anesthesiologist and Emergency Physician
Russian Federation
Doctor of Medical Sciences, Anesthesiologist and Emergency Physician
E. A. Pokushalov
E. N. Meshalkin Research Institute of Blood Circulation Pathology, Novosibirsk
Russian Federation
Doctor of Medical Sciences, Professor, Deputy Director for Scientific Experimental Research, Head of Interventional Cardiology Center
Russian Federation
Doctor of Medical Sciences, Professor, Deputy Director for Scientific Experimental Research, Head of Interventional Cardiology Center
V. A. Boboshko
E. N. Meshalkin Research Institute of Blood Circulation Pathology, Novosibirsk
Russian Federation
Candidate of Medical Sciences, Anesthesiologist and Emergency Physician
Russian Federation
Candidate of Medical Sciences, Anesthesiologist and Emergency Physician
References
1. Aleksin A.A. Post-operative atrial fibrillation in pulmonary surgery. Vestnik Anasteziol. i Reanimatol., 2014, no. 2, pp. 71-78. (In Russ.)
2. Chernyavskiy А.M., Pak I.А., Kareva Yu.E. Efficiency of various ways of ablaton for persistent atrial fibrillation during coronary artery bypass graft. Patologiya Krovoobr. i Kardiokhirurgiya, 2015, vol. 19, no. 4, pp. 54-60. (In Russ.)
3. Abacilar A.F., Dogan O.F. Levosimendan use decreases atrial fibrillation in patients after coronary artery bypass grafting: a pilot study. Heart Surg. Forum, 2013, vol. 16, pp. E287−Е294.
4. Acikel S., Bozbas H., Gultekin B., et al: Comparison of the efficacy of metoprolol and carvedilol for preventing atrial fibrillation after coronary bypass surgery. Int. J. Cardiol., 2008, vol. 126, pp. 108-113.
5. Adams D.C., Heyer E.J., Simon A.E. et al. Incidence of atrial fibrillation after mild or moderate hypothermic cardiopulmonary bypass. Crit. Care Med., 2000, vol. 28, pp. 309-311.
6. Alameddine A.K., Visintainer P., Alimov V.K. et al. Blood transfusion and the risk of atrial fibrillation after cardiac surgery. J. Card. Surg., 2014, vol. 29, pp. 593-599.
7. Alghamdi A.A., Al-Radi O.O., Latter D.A. Intravenous magnesium for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and meta-analysis. J. Card. Surg., 2005, vol. 20, pp. 293-299.
8. Anselmi A., Possati G., Gaudino M. Postoperative inflammatory reaction and atrial fibrillation: simple correlation or causation? Ann. Thorac. Surg., 2009, vol. 88, pp. 326-333.
9. Auer J., Weber T., Berent R. et al. Postoperative atrial fibrillation independently predicts prolongation of hospital stay after cardiac surgery. J. Cardiovasc. Surg. (Torino), 2005, vol. 46, pp. 583-588.
10. Bagshaw S.M., Galbraith P.D., Mitchell L.B. et al. Prophylactic amiodarone for prevention of atrial fibrillation after cardiac surgery: a meta-analysis. Ann. Thorac. Surg., 2006, vol. 82, pp. 1927-1937.
11. Bakhtiary F., Therapidis P., Dzemali P. et al. Impact of high thoracic epidural anesthesia on incidence of perioperative atrial fibrillation in off-pump coronary bypass grafting: a prospective randomized study. J. Thorac. Cardiovasc. Surg., 2007, vol. 134, pp. 460-464.
12. Beaulieu Y., Denault A.Y., Couture P. et al. Perioperative intravenous amiodarone does not reduce the burden of atrial fibrillation in patients undergoing cardiac valvular surgery. Anesthesiology, 2010, vol. 112, pp. 128-137.
13. Blessberger H., Kammler J., Domanovits H. et al. Perioperative beta-blockers for preventing surgery-related mortality and morbidity. Cochrane Database Syst Rev., 2014, vol. 18, no. 9, CD004476.
14. Bothe W., Olschewski M., Beyersdorf F. et al: Glucose-insulin-potassium in cardiac surgery: a meta-analysis. Ann. Thorac. Surg., 2004, vol. 78, pp. 1650-1657.
15. Burgess D.C., Kilborn M.J., Keech A.C. Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: A meta-analysis. Eur. Heart J., 2006, vol. 27, pp. 2846-2857.
16. Calò L., Bianconi L., Colivicchi F. et al. N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J. Am. Coll. Cardiol., 2005, vol. 45, pp. 1723-1728.
17. Chello M., Patti G., Candura D. et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Crit. Care Med., 2006, vol. 34, pp. 660-667.
18. Chen P.S., Chen L.S., Fishbein M.C. et al. Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy. Circ. Res., 2014, vol. 114, pp. 1500-1515.
19. Chrysostomou C., Sanchez-de-Toledo J., Wearden P. et al. Perioperative use of dexmedetomidine is associated with decreased incidence of ventricular and supraventricular tachyarrhythmias after congenital cardiac operations. Ann. Thorac. Surg., 2011, vol. 92, pp. 964-972.
20. Connolly S.J., Cybulsky I., Lamy A. et al. Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: The β-Blocker Length Of Stay (BLOS) study. Am. Heart J., 2003, vol. 145, pp. 226-232.
21. Dieleman J.M., Nierich A.P., Rosseel P.M. et al. Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial. JAMA, 2012, vol. 308, pp. 1761-1767.
22. Echahidi N., Pibarot P., O'Hara G. et al. Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery. J. Am. Coll. Cardiol., 2008, vol. 51, pp. 793-801.
23. Ehrlich J.R., Cha T.J., Zhang L. et al. Cellular electrophysiology of canine pulmonary vein cardiomyocytes: action potential and ionic current properties. J. Physiol., 2003, vol. 551, pp. 801-813.
24. Gillespie E.L., White C.M., Kluger J. et al. Cost-effectiveness of amiodarone for prophylaxis of atrial fibrillation after cardiothoracic surgery. Pharmacotherapy, 2006, vol. 26, pp. 499-504.
25. Halonen J., Halonen P., Järvinen O. et al. Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a randomized controlled study. JAMA, 2007, vol. 297, pp. 1562-1567.
26. Hemmerling T.M., Minardi C., Zaouter C. et al. Sevoflurane causes less arrhythmias than desflurane after off-pump coronary artery bypass grafting: a pilot study. Ann. Card Anaesth., 2010, vol. 13, pp. 116-122.
27. Katritsis D.G., Pokushalov E.A., Romanov A. et al. Autonomic denervation added to pulmonary vein isolation for paroxysmal atrial fibrillation: a randomized clinical trial. J. Am. Coll. Cardiol., 2013, vol. 62, pp. 2318-2325.
28. Kerin N.Z., Jacob S. The efficacy of sotalol in preventing postoperative atrial fibrillation: a meta-analysis. Am. J. Med., 2011, vol. 124, pp. 875.e1–875.e9.
29. Kim Y.M., Kattach H., Ratnatunga C. et al. Association of atrial nicotinamide adenine dinucleotide phosphate oxidase activity with the development of atrial fibrillation after cardiac surgery. J. Am. Coll. Cardiol., 2008, vol. 51, pp. 68-74.
30. Klemperer J.D., Klein I.L., Ojamaa K. et al. Triiodothyronine therapy lowers the incidence of atrial fibrillation after cardiac operations. Ann. Thoracic Surgery, 1996, vol. 61, pp. 1323-1329.
31. Klinger R.Y., Thunberg C.A., White W.D. Intraoperative magnesium administration does not reduce postoperative atrial fibrillation after cardiac surgery. Anesth Analg., 2015, vol. 121, no. 4, pp. 861-867.
32. Kolh P., Windecker S., Alfonso F. et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur. J. Cardiothoracic Surg., 2014, vol. 46, pp. 517-592.
33. Kromann N., Green A. Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950−1974. Acta Med. Scand., 1980, vol. 208, pp. 401-406.
34. Maesen B., Nijs J., Maessen J. et al. Post-operative atrial fibrillation: a maze of mechanisms. Europace, 2012, vol. 14, pp. 159-174.
35. Maniar P.B., Balcetyte-Harris N., Tamis J.E. et al. Intravenous versus oral beta-blockers for prevention of post-CABG atrial fibrillation in high-risk patients identified by signal-averaged ECG: lessons of a pilot study. Card. Electrophysiol. Rev., 2003, vol. 7, pp. 1158-1161.
36. Mitchell L.B., Exner D.V., Wyse D.G. et al. Prophylactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replacement, or repair: PAPABEAR: a randomized controlled trial. JAMA, 2005, vol. 294, pp. 3093-3100.
37. Mitchell L.B. Incidence, timing and outcome of atrial tachyarrhythmias after cardiac surgery, In Steinberg JS (ed): Atrial fibrillation after cardiac surgery. Norwell, MA, Kluwer Academic Publishers. 2000, pp. 37-50.
38. Mozaffarian D., Marchioli R., Macchia A. et al. Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for prevention of post-operative atrial fibrillation (OPERA) randomized trial. JAMA, 2012, vol. 308, pp. 2001-2011.
39. Nasso G., Costantini C., Petralia A. et al. A new extracorporeal vacuum-assisted device to optimize cardiopulmonary bypass. Comparison with the conventional system. Interact. Cardiovasc. Thorac. Surg., 2011, vol. 12, pp. 591-595.
40. Patti G., Chello M., Candura D. et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation, 2006, vol. 114, pp. 1455-1461.
41. Pokushalov E., Romanov A., Corbucci G. et al. Benefit of ablation of first diagnosed paroxysmal atrial fibrillation during coronary artery bypass grafting: a pilot study. Eur. J. Cardiothorac. Surg., 2012, vol. 41, pp. 556-560.
42. Pokushalov E., Romanov A., Artyomenko S. Left atrial ablation at the anatomic areas of ganglionated plexi for paroxysmal atrial fibrillation. Pacing and Clinical Electrophysiology. 2010, vol. 33, no. 10, pp. 1231−1238.
43. Pokyshalov E.A, Kozlov B., Romanov A. et al. Botulinum toxin injection in epicardial fat pads can prevent recurrences of atrial fibrillation after cardiac surgery: results of a randomized pilot study. J. Am. Coll. Cardiol., 2014, vol. 64, pp. 628-629.
44. Rostagno C., Blanzola C., Pinelli F. et al. Atrial fibrillation after isolated coronary surgery. Incidence, long term effects and relation with operative technique. Heart Lung Vessel, 2014, vol. 6, pp. 171-179.
45. Sanjuán R., Blasco M., Carbonell N. et al. Preoperative use of sotalol versus atenolol for atrial fibrillation after cardiac surgery. Ann. Thorac. Surg., 2004, vol. 77, pp. 838-843.
46. Steinberg J.S. Postoperative atrial fibrillation: a billion-dollar problem. J. Am. Coll. Cardiol., 2004, vol. 43, pp. 1001-1003.
47. Wright D.G., Lefer D.J. Statin mediated protection of the ischemic myocardium. Vasc. Pharmacol., 2005, 42, pp. 265-270.
48. Yasunari K., Maeda K., Nakamura M. et al. Effects of carvedilol on oxidative stress in polymorphonuclear and mononuclear cells in patients with essential hypertension. Am. J. Med., 2004, vol. 116, pp. 460-465.
49. Zaman A.G., Alamgir F., Richens T. et al. The role of signal averaged P wave duration and serum magnesium as a combined predictor of atrial fibrillation after elective coronary artery bypass surgery. Heart, 1997, vol. 77, pp. 527-531.
50. Zhang B., Zhen Y., Tao A. et al. Polyunsaturated fatty acids for the prevention of atrial fibrillation after cardiac surgery: an updated meta-analysis of randomized controlled trials. J. Cardiol., 2014, vol. 63, pp. 53-59.
Review
For citations:
Lomivorotov V.V., Efremov S.M., Pokushalov E.A., Boboshko V.A. ATRIAL FIBRILLATION AFTER CARDIAC SURGERY: PATHOPHYSIOLOGY AND PREVENTION TECHNIQUES. Messenger of ANESTHESIOLOGY AND RESUSCITATION. 2017;14(1):58-66. (In Russ.) https://doi.org/10.21292/2078-5658-2017-14-1-58-66
Email this article 